Breathing Life Into COPD ManagementOngoing Monitoring, Pulmonary Rehabilitation, and Individualized Care
Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials.
Decramer M, et al. Lancet Respir Med. 2014;2(6):472-486.
Hurst JR, et al. N Engl J Med. 2010;363(12):1128-1138.
Effect of early follow-up after hospital discharge on outcomes in patients with heart failure or chronic obstructive pulmonary disease: a systematic review.
Health Quality Ontario. Ont Health Technol Assess Ser. 2017;17(8):1-37.
Influence of COPD Assessment Text (CAT) evaluation and rehabilitation education guidance on the respiratory and motor functions of COPD patients.
Liu J, et al. Open Med (Wars). 2015;10(1):394-398.
Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison.
Mahler DA, et al. Thorax. 2012;67(9):781-788.
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
Martinez FJ, et al. Lancet. 2015;385(9971):857-866.
Nantsupawat T, et al. Chron Respir Dis. 2012;9(2):93-98.
Puhan MA, et al. Cochrane Database Syst Rev. 2016;12:CD005305.
The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.
Schnell K, et al. BMC Pulm Med. 2012;12:26.
Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease.
Sharma G, et al. Arch Intern Med. 2010;170(18):1664-1670.
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.
Spruit MA, et al. Am J Respir Crit Care Med. 2013;188(8):e13-e64.
Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting.
Yawn BP, et al. Int J Chron Obstruct Pulmon Dis. 2012;7:495-502.
Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.
Yawn BP, Thomashow B. Int J Gen Med. 2011;4:665-676.
Barbara P. Yawn, MD, MSc, FAAFP
Module 1 of 4
Module 2 of 4
Module 3 of 4
Module 4 of 4
Differential Diagnosis and Comprehensive Management Strategies
Optimizing Maintenance Therapy Across Healthcare Settings
Improving Outcomes for Patients with COPD
Collaborative Approaches to Guideline-Concordant Patient Care
New Strategies for Individualizing Long-term Care
A New Era in Precision Medicine
Evolving Best Practices to Optimize Outcomes
Consensus and Controversies on the Road to Precision Medicine
Debates and Discussions About Personalizing Patient Management
Differential Diagnosis, Multidisciplinary Management, and Patient Engagement
From Guideline Recommendations to Daily Clinical Decision-Making
Improving Patient Outcomes Through Shared Clinical Decision Making
Interdisciplinary Management of Patients With Severe Asthma
Optimizing Management Strategies in Moderate-to-Severe Atopic Dermatitis